Lactoferrin is one of the most functionally valuable proteins in mammalian milk — antimicrobial, iron-modulating, gut-supportive, immune-enhancing. The science is robust. The applications are broad. The problem is supply.

Bovine lactoferrin constitutes roughly 0.02% of cow's milk by weight. Extracting meaningful quantities requires processing enormous volumes of whey, a byproduct already under demand pressure from the protein isolate market. Current global production sits around 200–300 metric tons annually. Prices range from $300–500/kg, sometimes spiking higher during supply disruptions.

The math doesn't scale. Infant formula manufacturers, supplement brands, and functional food companies are all competing for the same constrained supply. Demand continues to rise, particularly in Asia-Pacific markets, while production capacity remains tethered to dairy infrastructure that can't expand fast enough.

There's also the saturation problem. Bovine lactoferrin averages approximately 20% iron saturation. For applications targeting iron bioavailability, this limits efficacy at standard inclusion rates.

Alpine Bio's plant-grown lactoferrin breaks both constraints. Production in soybeans decouples supply from dairy entirely — no whey dependency, no seasonal variation, no herd limitations. Agricultural scale replaces extraction bottlenecks.

The iron profile is also different. Our native lactoferrin reaches over 60% iron saturation, 3 to 4x higher than bovine. This enables either stronger iron delivery at equivalent doses or equivalent delivery at lower inclusion rates.

Same protein. Different economics. Different performance ceiling.